|
Volumn 15, Issue 5, 2001, Pages 448-451
|
Verrucous form of chilblain lupus erythematosus
|
Author keywords
Chilblain lupus; Collagen hyalinization; Verrucous form
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
CELL NUCLEUS ANTIGEN;
COMPLEMENT COMPONENT C3;
COMPLEMENT COMPONENT C4;
CORTICOSTEROID;
HYDROXYCHLOROQUINE;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
RHEUMATOID FACTOR;
ADULT;
ARTICLE;
CASE REPORT;
CELL INFILTRATION;
CHEEK MUCOSA;
CLINICAL FEATURE;
COLD INJURY;
COLLAGEN DEGRADATION;
DERMIS;
DISEASE COURSE;
EPIDERMODYSPLASIA VERRUCIFORMIS;
ERYTHROCYTE;
ERYTHROCYTE SEDIMENTATION RATE;
EXTRAVASATION;
FEMALE;
FINGER;
FOOT SOLE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
HYALINE DEGENERATION;
HYPERKERATOSIS;
HYPOCOMPLEMENTEMIA;
IMMUNOFLUORESCENCE;
KERATINOCYTE;
LABORATORY TEST;
LEUKOPENIA;
LIP;
LUPUS ERYTHEMATOSUS;
LYMPHOCYTE;
PATIENT CARE;
PRIORITY JOURNAL;
REDUCTION;
SKIN BIOPSY;
SYSTEMIC DISEASE;
THROMBOCYTOPENIA;
TOE;
BIOPSY, NEEDLE;
CHILBLAINS;
FEMALE;
FOLLOW-UP STUDIES;
FOOT DERMATOSES;
HAND DERMATOSES;
HUMANS;
HYDROXYCHLOROQUINE;
KERATOSIS;
LUPUS ERYTHEMATOSUS, CUTANEOUS;
METHYLPREDNISOLONE;
MIDDLE AGED;
MOUTH MUCOSA;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
EID: 0034755544
PISSN: 09269959
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1468-3083.2001.00346.x Document Type: Article |
Times cited : (18)
|
References (9)
|